STEPHANIE CANAL: Open Payments
NPI 1255697561 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 67 payments from 14 companies in 2025. Trend: 2023 $1,560 · 2024 $1,393 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 24 | $444 |
| Otsuka America Pharmaceutical, Inc. | 8 | $150 |
| Supernus Pharmaceuticals, Inc. | 5 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $79 |
| Lundbeck LLC | 3 | $74 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| ABBVIE INC. | 3 | $53 |
| Alkermes, Inc. | 3 | $52 |
Products named: HETLIOZ, REXULTI, Qelbree, CAPLYTA, FANAPT, TRINTELLIX, Auvelity, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
